Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-01-20

Clinical Trial Update: Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

View source ↗

Summary

A completed clinical trial update examining the association between macular pigment optical density and Complement Factor H genetic variants in subjects with ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sequenom, Inc. | Conditions: Age-related Macular Degeneration, Choroidal Neovascular Age-related Macular Degeneration | Status: COMPLETED